Cymechs Inc (160980) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Cymechs Inc stock KRW 33,561, price KRW 15,270, upside +119.8%, quality 68 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 7,008 KRW – 46,500 KRW · fair‑value band 25,171 KRW – 41,951 KRW · the 15,270 KRW price screens below the 33,561 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 8, 2026.
Follow Cymechs in your weekly email
Every Wednesday you see whether Cymechs is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CYMECHS Inc., a tool automation company, engages in the provision of core system components for semiconductor manufacturing in South Korea. The company offers transfer-equipment, such as transfer modules, EFEM, aligners, LPM, ATM robot for EFEM, and vacuum robot with transfer chambers.
Show moreShow less
It is also involved in the provision of intelligent robot solutions. The company was incorporated in 2005 and is headquartered in Hwaseong-si, South Korea.
Stock analysis
Cymechs Inc (160980) currently trades at 15,270 KRW, while our model-based Fair Value estimate is 33,561 KRW, implying the stock looks roughly 55% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 44,809 KRW per share, and 20 of the 26 models we run sit above the 15,270 KRW price.
Bear case: the Asset-Based group reads lowest at 10,231 KRW, and 6 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: 25,171 KRW (bear) to 41,951 KRW (bull), the price of 15,270 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Technology sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Cymechs Inc reported revenue of 164B KRW in FY2025 versus 242B KRW in FY2021, a compound −9.2%/yr. Reported net income was 14.9B KRW in FY2025, compounding −11.5%/yr from FY2021.
Key figures
Market cap 167B KRW (≈ $123M) Micro · P/E ratio 13.0 · P/S ratio 0.96 · EPS (TTM) 1,532 KRW · Dividend yield 2.6% · Net margin 9.7% · Return on equity 8.7% · Return on assets (EBIT) 9.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 67% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −7% fair-value upside, at 120%, 160980 screens cheaper than that median.
Fair Value models
Bear25,171 KRWFair Value 33,561 KRWBull41,951 KRW
Price 15,270 KRW · Upside +119.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (971.02 KRW per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF36,400 KRW45,198 KRW55,317 KRW82
Growth DCF36,415 KRW44,078 KRW52,420 KRW80
Owner Earnings24,952 KRW30,182 KRW36,197 KRW78
All 26 models by family
DCF Models
FCF DCF36,400 KRW45,198 KRW55,317 KRW82
Owner Earnings24,952 KRW30,182 KRW36,197 KRW78
5Y Revenue Exit31,222 KRW40,514 KRW51,813 KRW74
5Y EBITDA Exit36,274 KRW49,783 KRW65,017 KRW76
5Y P/E Exit34,770 KRW47,024 KRW59,441 KRW72
10Y Revenue Exit33,078 KRW40,889 KRW50,476 KRW68
10Y EBITDA Exit35,972 KRW45,917 KRW58,285 KRW70
10Y P/E Exit35,219 KRW44,420 KRW54,988 KRW65
Earnings-Based
Graham-Dodd9,299 KRW26,636 KRW35,119 KRW65
Lynch FV5,466 KRW7,809 KRW10,151 KRW61
PEG = 1.05,466 KRW7,809 KRW10,151 KRW57
EPV20,361 KRW21,638 KRW22,649 KRW74
Dividend Discount
Gordon GGM2,027 KRW3,179 KRW3,937 KRW69
DDM Multi-Stage2,027 KRW2,852 KRW3,437 KRW67
Multiples
P/E Multiple28,718 KRW38,291 KRW47,864 KRW63
P/S Multiple17,436 KRW23,248 KRW29,060 KRW58
P/B Multiple12,108 KRW16,143 KRW20,179 KRW55
EV/EBIT36,047 KRW48,898 KRW61,748 KRW66
EV/EBITDA29,533 KRW40,213 KRW50,893 KRW67
EV/Revenue16,984 KRW25,338 KRW33,691 KRW53
Asset-Based
NCAV (Graham)6,752 KRW10,231 KRW12,789 KRW54
Growth DCF
Growth DCF36,415 KRW44,078 KRW52,420 KRW80
Rev-Margin DCF31,222 KRW40,997 KRW52,149 KRW74
Economic Profit
Residual Income12,665 KRW12,655 KRW13,298 KRW76
ROIC Compounder20,666 KRW22,503 KRW24,355 KRW72
Growth Earnings
Growth-Adj P/E22,545 KRW32,207 KRW41,870 KRW67
The fair value above starts from this blend and is adjusted for a cyclical peak year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−0.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.0%
Start year 2020 (pandemic). Over 10 years: +11.5% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−6.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−9.4%
Dividend (yield on the price)2.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−9.4% vs 5.8%, slowing
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−18.9%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −20.5% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductor Equipment & Materials · 235 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Cymechs Inc Fair Value". https://www.fairvalue-calculator.com/stock/160980
Frequently asked questions
Is Cymechs Inc (160980) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 33,561 KRW versus a price of 15,270 KRW, about +120% upside (undervalued).
What is the fair value of 160980?
Our model-based fair value for Cymechs Inc is 33,561 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 15,270 KRW.
What is the quality score of 160980?
Cymechs Inc has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cymechs Inc (160980)?
Our model-based price target is the fair value of 33,561 KRW (as of Nov 8, 2026) from 26 valuation models. Cautious scenario 25,171 KRW, optimistic scenario 41,951 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cymechs Inc stock forecast for 2026?
Our models put fair value at 33,561 KRW, about +120% upside versus a price of 15,270 KRW (undervalued). Cautious scenario 25,171 KRW, optimistic scenario 41,951 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cymechs Inc (160980)?
Cymechs Inc reported trailing-twelve-month revenue of about 173B KRW (latest available figure, as of Nov 8, 2026).
Does Cymechs Inc pay a dividend?
Cymechs Inc currently shows a dividend yield of 2.62% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Cymechs Inc (160980) and when is the ex-dividend date?
Cymechs Inc pays a dividend of 400.00 KRW per share a year, a dividend yield of 2.6%. The last ex-dividend date was Dec 29, 2025. A dividend has been paid every year since at least 2015. The payout ratio is 26.1% of earnings. Free cash flow covers the dividend 9.80 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Cymechs Inc (160980)?
For today's price to be fair in a discounted-cash-flow model, Cymechs Inc would have to grow free cash flow by -18.9 % per year for five years (discount rate 14.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -1.0 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 160980 use?
Our models discount Cymechs Inc at 14.3 %: a base by market capitalisation (micro), damped by beta 1.36, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cymechs Inc that is -18.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (14.3 %) and the same formula as our fair value.
How much growth has Cymechs Inc (160980) delivered so far?
Over the past 5 years revenue at Cymechs Inc grew -1.0 % a year. The price currently implies free-cash-flow growth of -18.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cymechs Inc (160980) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Cymechs Inc (-18.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cymechs Inc (160980)?
The free-cash-flow yield on the price is 25.67 %: that much free cash flow Cymechs Inc produces per unit of market value. When it exceeds the discount rate of our models (14.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cymechs Inc (160980)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cymechs Inc it is 33,561 KRW per share (as of Nov 8, 2026), against a price of 15,270 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Cymechs Inc stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 160980 trades below its calculated fair value: price 15,270 KRW, fair value 33,561 KRW, a gap of about +120% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 160980?
No. The price is what the market pays today (15,270 KRW); the fair value is what the company's own numbers justify (33,561 KRW). For Cymechs Inc the two are 18,291 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cymechs Inc worth?
The market values Cymechs Inc at about 167B KRW (market capitalisation, as of Nov 8, 2026). Per share that is 15,270 KRW; our models calculate a fair value of 33,561 KRW per share.
What do the bullish and bearish scenarios say about 160980?
Our models span a range for Cymechs Inc: cautious scenario 25,171 KRW, base 33,561 KRW, optimistic 41,951 KRW per share (as of Nov 8, 2026, price 15,270 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 160980?
Cymechs Inc trades at a price-to-earnings ratio of 13.0 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 33,561 KRW is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings: 10.1. Other multiples: P/B 0.9, P/S 1.0, EV/EBITDA 2.9.
How solid is the balance sheet of Cymechs Inc (160980)?
Balance-sheet figures for Cymechs Inc (as of Nov 8, 2026): return on equity 8.7%. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is 160980 from its 52-week high?
Cymechs Inc trades at 15,270 KRW, about 67% below its 52-week high of 46,500 KRW and 9% above the low of 14,000 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 33,561 KRW is for.
Which stocks are comparable to Cymechs Inc?
From the same area (Technology) we also value ASML Holding, Applied Materials, Inc, Lam Research Corporation, KLA Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cymechs Inc stock attractive at the current price?
The data as of Nov 8, 2026: price 15,270 KRW, calculated fair value 33,561 KRW (+120%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 160980 calculated?
We run Cymechs Inc through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 33,561 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Cymechs Inc currently trades 55% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cymechs Inc (160980)?
The closing price on Nov 6, 2026 was 15,270 KRW. Our model-based fair value is 33,561 KRW, about +120% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cymechs Inc right now?
The price is below even our cautious bear case (25,171 KRW). The market is more pessimistic than our downside scenario. Solid quality (68/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Cymechs Inc
How large is the market capitalisation of Cymechs Inc (160980)?
The market capitalisation of Cymechs Inc is 167B KRW (≈ $123M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cymechs Inc (160980)?
The price-to-sales ratio of Cymechs Inc is 0.96 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cymechs Inc (160980)?
Earnings per share at Cymechs Inc are 1,532 KRW (price ÷ EPS = P/E 13.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cymechs Inc (160980)?
The dividend yield of Cymechs Inc is 2.6% (payout 26.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cymechs Inc (160980)?
The net margin of Cymechs Inc is 9.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cymechs Inc (160980)?
The return on equity (ROE) of Cymechs Inc is 8.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cymechs Inc (160980)?
On an EBIT basis the return on assets of Cymechs Inc is 9.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cymechs Inc (160980)?
The operating margin of Cymechs Inc is 18.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cymechs Inc (160980)?
Revenue at Cymechs Inc is growing +29.4% versus a year earlier (3y avg −5.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cymechs Inc (160980)?
Earnings per share at Cymechs Inc are growing +50.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Cymechs Inc (160980) carry?
The net debt of Cymechs Inc is 27.4B KRW (fiscal year 2022, ≈ 0.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cymechs Inc in the live analysis
One click puts Cymechs Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026